Cargando…
Assessment of latent infections in patients receiving biological therapies
The use of biological (or targeted) therapies constitutes a major advance in the management of autoinflammatory and malignant diseases. However, due to the selective effect of these agents on the host’s immune response, reactivation of certain pathogens that cause latent infection is to be expected....
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sociedad Española de Quimioterapia
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755370/ https://www.ncbi.nlm.nih.gov/pubmed/31475814 |